Performance of Newly Listed Shares as on 17th February 2012

These IPO’s were listed during the July September 2011 quarter

Name Date of Listing Issue Price Closing  Price Closing Price % Gain Loss  Change Over Lifetime   Fall from  Fall as % from
17th Feb 10th Feb  Over Week  lssue Price High High in Rs Lifetime High
Birla Pacific Medspa 7thJuly 10.00 6.87 7.50 -8.40 -31.30 30.70 -23.83 -238.30
Rushil Décor 7thJuly 72.00 159.60 174.75 -8.67 121.67 207.00 -47.40 -65.83
Readymade Steel India 13th July 108.00 57.55 60.30 -4.56 -46.71 117.75 -60.20 -55.74
Bhartiya Global Infomedia 28th July 82.00 9.15 9.18 -0.33 -88.84 84.00 -74.85 -91.28
Inventure Growth & Securities 4th Aug 117.00 232.05 219.10 5.91 98.33 256.75 -24.70 -21.11
L&T Finance Holdings 12th Aug 52.00 52.50 48.35 8.58 0.96 53.00 -0.50 -0.96
Tree House Education & Acessories 26th Aug 135.00 217.20 224.55 -3.27 60.89 211.80 5.40 4.00
Brooks Laboratories 5th Sept 100.00 24.73 21.33 15.94 -75.27 131.10 -106.37 -106.37
TD Power Systems 8th Sept 256.00 251.10 251.35 -0.10 -1.91 321.00 -69.90 -27.30
SRS 16th Sept 58.00 34.05 33.70 1.04 -41.29 61.40 -27.35 -47.16
PG Electroplast 26th Sept 210.00 189.15 193.05 -2.02 -9.93 548.00 -358.85 *-170.88

* I have received lot of queries about the last column “fall as % from lifetime high” and the fact that it is more than 100%. The fact is that many of these poor fundamental shares have gone up sharply on the day of listing or for a brief period and then have fallen sharply. The base of all issues is the issue price and because a share cannot trade at negative value it can never fall more than 99%.

This column highlights the extent of fall from the lifetime high and depicts the same as a percentage of the issue price.

For example in the case of Birla Medspa the high is Rs 30.70 which is a gain of 307% on the issue price and the share has fallen below the issue price of Rs 10 to now trade at Rs 6.78. This translates into the loss of 239.20% from the lifetime high.

Both comments and pings are currently closed.

Comments are closed.

Subscribe to RSS Feed Follow me on Twitter!